정신질환에서 Loudness Dependence of Auditory Evoked Potential (LDAEP)의 임상적 의미

키워드

참고문헌 (70)

1. Lucki I, "The spectrum of behaviors influenced by serotonin", Biol Psychiatry, 44, pp.151~162 (1998)
2. Hegerl U, "Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis", Biol Psychiatry, 33, pp.173~187 (1993)
3. Juckel G, "Auditory-evoked potentials as indicator of brain serotonergic activity--first evidence in behaving cats", Biol Psychiatry, 41, pp.1181~1195 (1997)
4. Hensch T, "Further evidence for an association of 5-HTTLPR with intensity dependence of auditory-evoked potentials", Neuropsychopharmacology, 31, pp.2047~2054 (2006)
5. Linka T, "The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression", Neurosci Lett, 367, pp.375~378 (2004)
6. Linka T, "The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression", Pharmacopsychiatry, 38, pp.139~143 (2005)
7. Linka T, "The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences", J Affect Disord, 103, pp.139~145 (2007)
8. Murphy DL, "Peripheral indices of central serotonin function in humans", Ann N Y Acad Sci, 600, pp.282~296 (1990)
9. Pletscher A, "Platelets as models: use and limitations", Experientia, 44, pp.152~155 (1988)
10. Auerbach SB, "Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release", Brain Res, 499, pp.281~290 (1989)
11. Boadle-Biber MC, "Regulation of serotonin synthesis", Prog Biophys Mol Biol, 60, pp.1~15 (1993)
12. Tyce GM, "Origin and metabolism of serotonin", J Cardiovasc Pharmacol, 16(Suppl 3), pp.S1~S7 (1990)
13. Cooper JR, "The Biochemical Basis of Neuropharmacology. 8th ed" (1996), Oxford University Press
14. Juckel G, "Auditory evoked potentials reflect serotonergic neuronal activity--a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus", Neuropsychopharmacology, 21, pp.710~716 (1999)
15. Manjarrez G, "N1", P2 component of auditory evoked potential reflect changes of the brain serotonin biosynthesis in rats, 2005, pp.8, 213~218
16. 박영민, "The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls", PROGRESS IN NEURO-PSYCHOPHARMACOLOGY BIOLOGICAL PSYCHIATRY, 34(2), pp.313~316 (2010), PERGAMON-ELSEVIER SCIENCE LTD
17. 양은경, "주요 우울 장애, 정신분열병, 양극성 장애 및 정상 대조군에서의 N100 진폭 경사", 생물정신의학, 16(3), pp.181~189 (2009), 대한생물정신의학회
18. Gudlowski Y, "Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity", Schizophr Res, 109, pp.141~147 (2009)
19. Woolley DW, "A biochemical and pharmacological suggestion about certain mental disorders", Proc Natl Acad Sci U S A, 40, pp.228~231 (1954)
20. Aghajanian GK, "Serotonin model of schizophrenia: emerging role of glutamate mechanisms", Brain Res Brain Res Rev, 31, pp.302~312 (2000)
21. van Veelen NM, "Dopamine, serotonin, and schizophrenia", Adv Neurol, 80, pp.425~429 (1999)
22. Harrison PJ, "The neuropathology of schizophrenia. A critical review of the data and their interpretation", Brain, 122, pp.593~624 (1999)
23. setoperone, "Am J Psychiatry", 2000, 1016~1018
24. Eastwood SL, "Expression of serotonin 5-HT (2A) receptors in the human cerebellum and alterations in schizophrenia", Synapse, 42, pp.104~114 (2001)
25. Salvadore G, "The neurobiology of the switch process in bipolar disorder: a review", J Clin Psychiatry, 71, pp.1488~1501 (2010)
26. 이승환, "높은 N100 진폭경사를 보이는 두 환자의 세로토닌 재흡수 억제제 이상반응", 대한정신약물학회지, 19(6), pp.341~347 (2008), 대한정신약물학회
27. Hegerl U, "Auditory evoked potentials and response to lithium prophylaxis", Pharmacopsychiatry, 20, pp.213~216 (1987)
28. Hegerl U, "Intensity dependence of auditory evoked potentials and clinical response to prophylactic lithium medication: a replication study", Psychiatry Res, 44, pp.181~190 (1992)
29. Rohayem J, "Predictors of prophylactic response to lithium", Encephale, 34, pp.394~399 (2008)
30. Hegerl U, "Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?", J Affect Disord, 62, pp.93~100 (2001)
31. Chen TJ, "Serotonin dysfunction and suicide attempts in major depressives: an auditory event-related potential study", Neuropsychobiology, 52, pp.28~36 (2005)
32. Linka T, "Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components", Psychiatry Res, 169, pp.139~143 (2009)
33. Young-Min Park, "Usefulness of LDAEP to Predict Tolerability to SSRIs in Major Depressive Disorder: A Case Report", PSYCHIATRY INVESTIGATION, 9(1), pp.80~82 (2012), 대한신경정신의학회
34. Fitzgerald PB, "A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression", J Affect Disord, 117, pp.212~216 (2009)
35. Juckel G, "Loudness dependence of auditory evoked potentials is not associated with polymorphisms or haplotypes in the serotonin transporter gene in a community-based sample of German healthy volunteers", Psychiatry Res, 153, pp.183~187 (2007)
36. Mulert C, "Prediction of treatment response in major depression: integration of concepts", J Affect Disord, 98, pp.215~225 (2007)
37. 박영민, "The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder", PSYCHOPHARMACOLOGY, 213(2-3), pp.625~632 (2011), SPRINGER
38. Kendler KS, "Clinical characteristics of major depression that predict risk of depression in relatives", Arch Gen Psychiatry, 56, pp.322~327 (1999)
39. Senkowski D, "Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder", Biol Psychiatry, 53, pp.304~314 (2003)
40. Lee SH, "Psychophysiological markers of anxiety disorders and anxiety symptoms" (2011), InTech
41. Furlong RA, "Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders", Am J Med Genet, 81, pp.58~63 (1998)
42. Ogilvie AD, "Polymorphism in serotonin transporter gene associated with susceptibility to major depression", Lancet, 347, pp.731~733 (1996)
43. 김도관, "Serotonin transporter gene polymorphism and antidepressant response", NEUROREPORT, 11(1), pp.215~219 (2000), LIPPINCOTT WILLIAMS WILKINS
44. Rausch JL, "Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome", Biol Psychiatry, 51, pp.723~732 (2002)
45. Serretti A, "Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity", Mol Psychiatry, 6, pp.586~592 (2001)
46. Zanardi R, "Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene", J Clin Psychopharmacol, 20, pp.105~107 (2000)
47. Lesch KP, "Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region", Science, 274, pp.1527~1531 (1996)
48. Hariri AR, "Serotonin transporter genetic variation and the response of the human amygdala", Science, 297, pp.400~403 (2002)
49. Pezawas L, "5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression", Nat Neurosci, 8, pp.828~834 (2005)
50. Williams RB, "Serotonin-related gene polymorphisms and central nervous system serotonin function", Neuropsychopharmacology, 28, pp.533~541 (2003)
51. Gallinat J, "Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing", Neuropsychopharmacology, 28, pp.530~532 (2003)
52. Strobel A, "Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential", Am J Med Genet B Neuropsychiatr Genet, 118B, pp.41~47 (2003)
53. Brocke B, "Biopsychological bases and behavioral correlates of sensation seeking: contributions to a multilevel validation", Pers Indiv Differ, 26, pp.1103~1123 (1999)
54. Prescott J, "The augmenting", reducing phenomenon in the auditory evoked potential, 1984, pp.19, 31~44
55. Juckel G, "Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder", J Clin Psychiatry, 68, pp.1206~1212 (2007)
56. Moret C, "The possible role of 5-HT (1B", D) receptors in psychiatric disorders and their potential as a target for therapy, 2000, pp.404, 1~12
57. Cyranowski JM, "Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model", Arch Gen Psychiatry, 57, pp.21~27 (2000)
58. Kornstein SG, "Gender differences in treatment response to sertraline versus imipramine in chronic depression", Am J Psychiatry, 157, pp.1445~1452 (2000)
59. Cosgrove KP, "Evolving knowledge of sex differences in brain structure, function, and chemistry", Biol Psychiatry, 62, pp.847~855 (2007)
60. Staley JK, "Sex differences in diencephalon serotonin transporter availability in major depression", Biol Psychiatry, 59, pp.40~47 (2006)
61. MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: a positron emission tomography study, "Psychiatry Res", 2010, 157~166
62. Walpurger V, "Effects of the menstrual cycle on auditory event-related potentials", Horm Behav, 46, pp.600~606 (2004)
63. Guille V, "Interaction of estrogen with central serotonergic mechanisms in human sensory processing: loudness dependence of the auditory evoked potential and mismatch negativity", J Psychopharmacol, 25, pp.1614~1622 (2011)
64. Gallinat J, "Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing", Pharmacopsychiatry, 38, pp.158~160 (2005)
65. 양은경, "남성 우울증 환자에서 흡연 유무에 따른 Loudness Dependence of the Auditory Evoked Potential의 차이", 대한정신약물학회지, 22(2), pp.89~95 (2011), 대한정신약물학회
66. Knott VJ, "Stimulus intensity control and the cortical evoked response in smokers and non-smokers", Psychophysiology, 15, pp.186~192 (1978)
67. Pritchard W, "Effects of nicotine and smoking on event-related potentials: a review", Nicotine Tob Res, 6, pp.961~984 (2004)
68. Ishikawa H, "Association between serotonin transporter gene polymorphism and smoking among Japanese males", Cancer Epidemiol Biomarkers Prev, 8, pp.831~833 (1999)
69. Heinz A, "A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity", Biol Psychiatry, 47, pp.643~649 (2000)
70. Mineur YS, "Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressantlike properties in male C57BL", 6J mice, 2007, pp.52, 1256~1262

관련 논문AI추천